Free Weekly Vaccines Industry Newsletter Get the latest news about Research Breakthroughs, R&D Trends, and Vaccine Production sent straight to your Inbox. Join over 30,000 lab research professionals who subscribe to FierceVaccines for FREE!
The vaccine targets infections with Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B, and is given as four doses between 6 weeks and 18 months of age. Both of these infections can cause meningitis.
Vaccine Therapeutics & Competitor Analysis Reports Available
Insight Pharma Reports and the Affiliated Reports Collection offer several reports focusing on vaccine therapeutics including; preventive, cancer, herpes, Tuberculosis, Malaria, Staphylococcal aureus, Dengue Virus, RSV, and more. For more info and a complete list of our reports, visit: www.InsightPharmaReports.com.
Vice President, Global Medical Affairs - Multiple Myeloma Job Celgene Corporation - Summit NJ US
Senior Director, Forecasting Job Celgene Corporation - Summit NJ US
Senior Director, Translational Development, Hematology / Oncology Job Celgene Corporation - San Francisco CA US
A publication ofFierceMarkets
FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Click here to get your free weekly email briefing today!